483
Abbott VascularFDA 483 - Abbott Vascular
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Abbott Vascular in Clonmel, Co. Tipperary, Ireland, identified issues with the validation of their BHT Content test method for stents. The firm's validation protocol and change order for the GCMS sample size were found to lack sufficient justification and did not adequately prove repeatability and reproducibility of the process. This indicates a concern regarding the robustness of their quality control testing.
- Company
- Abbott Vascular
- Product Type
- Device
Open in Dashboard
ID · 3634ebda-4086-40b3-b86e-4573dd37e47d